Novartis AG's 'biosimilar' drug sale blocked by U.S. appeals court

(Reuters) - A U.S. appeals court has blocked the sale of Novartis AG's recently approved "biosimilar" form of Neupogen, Amgen Inc's blockbuster drug used to prevent infections in cancer patients.Read more...